Anti beta 2 Glycoprotein 1 IgM-"Anti beta 2 Glycoprotein 1 IgM kit is an indirect enzymelinked immunosorbent assay designed for the quantitative measurement of IgM class antibodies directed against the β2 - India CDSCO Medical Device Registration

Anti beta 2 Glycoprotein 1 IgM-"Anti beta 2 Glycoprotein 1 IgM kit is an indirect enzymelinked immunosorbent assay designed for the quantitative measurement of IgM class antibodies directed against the β2 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000352_65576f26b2a3d76a1a6dc8c5146cd25a_365219419ee16ff7ce1a670687cff8b1. This device is marketed under the brand name c-ANCA. The license holder is Amindo Biologics Pvt. Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.